Summary:
A clinical trial of investigational medication for adults with schizophrenia experiencing acute exacerbations/relapse of psychosis.
Criteria:- Be 18-65 years old
- Be diagnosed with schizophrenia
- Be experiencing an acute exacerbation/relapse of symptoms
- Additional criteria apply
Qualified Participants May Receive:
Up to $6,100-$16,675 for time and travel-related expenses